| Vaccines |
1 |
0.98 |
| Hepatitis B Virus |
0 |
0.77 |
| Immunization |
0 |
0.77 |
| Tdap Vaccine |
0 |
0.74 |
| Pneumonia |
0 |
0.72 |
| HIV Infection |
0 |
0.66 |
| Human Papillomavirus |
0 |
0.64 |
| Patient Safety |
0 |
0.63 |
| Herpes Zoster |
0 |
0.62 |
| Biologic Therapy |
0 |
0.6 |
| COVID-19 Vaccine |
0 |
0.6 |
| Influenza Vaccine |
0 |
0.59 |
| Varicella-Zoster Virus |
0 |
0.37 |
| Pregnancy |
0 |
0.34 |
| Child |
0 |
0.31 |
| Adverse Effects |
0 |
0.28 |
| Rubella |
0 |
0.28 |
| MMR Vaccine |
0 |
0.25 |
| Postpartum |
0 |
0.24 |
| Food and Drug Administration (FDA) |
0 |
0.23 |
| Hepatitis A |
0 |
0.21 |
| Pneumococcal Vaccine |
0 |
0.19 |
| HPV Vaccine |
0 |
0.18 |
| Hepatitis B Vaccine |
0 |
0.17 |
| Pertussis |
0 |
0.14 |
| Otolaryngology |
0 |
0.13 |
| COVID-19 |
0 |
0.11 |
| Antigens |
0 |
0.1 |
| Measles |
0 |
0.1 |
| Mumps |
0 |
0.1 |
| Tetanus |
0 |
0.1 |
| Pediatric Respiratory Infections |
0 |
0.09 |
| Cancer |
0 |
0.07 |
| Cancer Vaccine |
0 |
0.07 |
| Critical Illness |
0 |
0.07 |
| Influenza |
0 |
0.07 |
| Insurance |
0 |
0.07 |
| Papillomavirus |
0 |
0.07 |
| Residency |
0 |
0.07 |
| Vaccines for Adult |
0 |
0.07 |
| Arthralgia |
0 |
0.06 |
| Cancer Pain |
0 |
0.06 |
| Fluid, Electrolyte, and Nutrition Management of the Newborn |
0 |
0.06 |
| Cerebrospinal Fluid |
0 |
0.05 |
| Electronic Medical Record |
0 |
0.05 |
| Genital Wart |
0 |
0.05 |
| Health Care Services |
0 |
0.05 |
| Liver Disease |
0 |
0.05 |
| Malaise and Fatigue |
0 |
0.05 |
| Pain Management |
0 |
0.05 |
| Postherpetic Neuralgia |
0 |
0.05 |
| Acute Pain |
0 |
0.04 |
| Adenovirus |
0 |
0.04 |
| Adherence |
0 |
0.04 |
| Analgesia |
0 |
0.04 |
| Anemia |
0 |
0.04 |
| Asplenia |
0 |
0.04 |
| Autism |
0 |
0.04 |
| Bell Palsy |
0 |
0.04 |
| Chlamydial Infection |
0 |
0.04 |
| Clinician Health and Well-Being |
0 |
0.04 |
| Cochlear Implant |
0 |
0.04 |
| Diphtheria |
0 |
0.04 |
| Fatigue |
0 |
0.04 |
| Fever |
0 |
0.04 |
| First Trimester Pregnancy |
0 |
0.04 |
| Gonorrhea |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Guillain-Barre Syndrome |
0 |
0.04 |
| Health Care Facilities, Manpower, and Services |
0 |
0.04 |
| Health Care Quality, Access, and Evaluation |
0 |
0.04 |
| Hepatitis |
0 |
0.04 |
| Herpes Zoster Vaccine |
0 |
0.04 |
| Immunoglobulin G (IgG) |
0 |
0.04 |
| Intravenous |
0 |
0.04 |
| Jobs |
0 |
0.04 |
| Liver |
0 |
0.04 |
| Lymphadenopathy |
0 |
0.04 |
| Match |
0 |
0.04 |
| Maternal-Fetal Medicine |
0 |
0.04 |
| Medical Life |
0 |
0.04 |
| Medical Records |
0 |
0.04 |
| Nausea |
0 |
0.04 |
| Neuralgia |
0 |
0.04 |
| Newborn |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Preventive Screening |
0 |
0.04 |
| Primary Care |
0 |
0.04 |
| Renal Disease |
0 |
0.04 |
| Rural Health |
0 |
0.04 |
| Skin Lesion |
0 |
0.04 |
| Splenectomy |
0 |
0.04 |
| Venous Thromboembolism (VTE) |
0 |
0.04 |
| Viral Exanthem |
0 |
0.04 |
| Wart |
0 |
0.04 |
| Revenue and Practice Management |
0 |
0.03 |
| Contraception |
0 |
0.02 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.02 |
| Hepatitis C Virus |
0 |
0.02 |
| Social Determinants of Health |
0 |
0.02 |
| Anaphylaxis |
0 |
0.01 |
| Headache |
0 |
0.01 |
| Nutritional Support |
0 |
0.01 |
| Pneumococcal Infection |
0 |
0.01 |
| Sickle Cell Anemia |
0 |
0.01 |
| Thromboembolism |
0 |
0.01 |